Curi RMB Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Sell |
67,680
-3,628
| -5% | -$94.9K | 0.03% | 377 |
|
|
2026
Q1 | $2M | Sell |
71,308
-1,001
| -1% | -$26.6K | 0.04% | 332 |
|
|
2025
Q4 | $1.8M | Sell |
72,309
-1,032
| -1% | -$26K | 0.03% | 357 |
|
|
2025
Q3 | $1.87M | Sell |
73,341
-2,948
| -4% | -$72.8K | 0.03% | 337 |
|
|
2025
Q2 | $1.85M | Buy |
76,289
+57,456
| +305% | +$1.34M | 0.04% | 339 |
|
|
2025
Q1 | $477K | Sell |
18,833
-18,973
| -50% | -$496K | 0.01% | 393 |
|
|
2024
Q4 | $1M | Sell |
37,806
-17,964
| -32% | -$487K | 0.02% | 335 |
|
|
2024
Q3 | $1.61M | Buy |
55,770
+2,487
| +5% | +$72.5K | 0.04% | 291 |
|
|
2024
Q2 | $1.49M | Buy |
53,283
+1,926
| +4% | +$53K | 0.04% | 299 |
|
|
2024
Q1 | $1.43M | Buy |
51,357
+17,042
| +50% | +$473K | 0.03% | 311 |
|
|
2023
Q4 | $988K | Sell |
34,315
-111
| -0.3% | -$3.35K | 0.03% | 293 |
|
|
2023
Q3 | $1.14M | Sell |
34,426
-938
| -3% | -$33.2K | 0.04% | 269 |
|
|
2023
Q2 | $1.3M | Buy |
35,364
+650
| +2% | +$25.3K | 0.04% | 260 |
|
|
2023
Q1 | $1.42M | Buy |
34,714
+10,152
| +41% | +$438K | 0.05% | 252 |
|
|
2022
Q4 | $1.26M | Sell |
24,562
-171
| -0.7% | -$8.2K | 0.04% | 258 |
|
|
2022
Q3 | $1.08M | Buy |
24,733
+3,808
| +18% | +$185K | 0.04% | 273 |
|
|
2022
Q2 | $1.1M | Buy |
20,925
+183
| +0.9% | +$9.33K | 0.04% | 267 |
|
|
2022
Q1 | $1.07M | Sell |
20,742
-20
| -0.1% | -$1.04K | 0.03% | 244 |
|
|
2021
Q4 | $1.23M | Sell |
20,762
-11,203
| -35% | -$555K | 0.04% | 251 |
|
|
2021
Q3 | $1.38M | Buy |
31,965
+526
| +2% | +$23.3K | 0.05% | 235 |
|
|
2021
Q2 | $1.23M | Buy |
31,439
+604
| +2% | +$23.5K | 0.04% | 261 |
|
|
2021
Q1 | $1.12M | Sell |
30,835
-1,237
| -4% | -$43.9K | 0.04% | 251 |
|
|
2020
Q4 | $1.18M | Sell |
32,072
-1,431
| -4% | -$52.5K | 0.04% | 293 |
|
|
2020
Q3 | $1.17M | Sell |
33,503
-598
| -2% | -$21K | 0.05% | 266 |
|
|
2020
Q2 | $1.06M | Sell |
34,101
-817
| -2% | -$27.8K | 0.05% | 297 |
|
|
2020
Q1 | $1.08M | Sell |
34,918
-34,527
| -50% | -$1.18M | 0.05% | 284 |
|
|
2019
Q4 | $2.58M | Sell |
69,445
-1,287
| -2% | -$45.8K | 0.07% | 239 |
|
|
2019
Q3 | $2.41M | Buy |
70,732
+466
| +0.7% | +$16.9K | 0.06% | 269 |
|
|
2019
Q2 | $2.89M | Sell |
70,266
-9,466
| -12% | -$376K | 0.07% | 258 |
|
|
2019
Q1 | $3.21M | Sell |
79,732
-65,869
| -45% | -$2.64M | 0.08% | 255 |
|
|
2018
Q4 | $6.03M | Sell |
145,601
-29,683
| -17% | -$1.23M | 0.15% | 161 |
|
|
2018
Q3 | $7.33M | Buy |
175,284
+94,633
| +117% | +$3.64M | 0.18% | 158 |
|
|
2018
Q2 | $2.78M | Sell |
80,651
-122,638
| -60% | -$4.19M | 0.07% | 312 |
|
|
2018
Q1 | $6.85M | Sell |
203,289
-12,876
| -6% | -$443K | 0.18% | 160 |
|
|
2017
Q4 | $7.43M | Buy |
216,165
+14,249
| +7% | +$486K | 0.19% | 157 |
|
|
2017
Q3 | $6.84M | Buy |
201,916
+120,091
| +147% | +$3.86M | 0.18% | 177 |
|
|
2017
Q2 | $2.61M | Buy |
81,825
+47,830
| +141% | +$1.51M | 0.07% | 325 |
|
|
2017
Q1 | $1.1M | Buy |
33,995
+6,834
| +25% | +$215K | 0.05% | 292 |
|
|
2016
Q4 | $837K | Buy |
27,161
+13,051
| +92% | +$398K | 0.05% | 261 |
|
|
2016
Q3 | $454K | Sell |
14,110
-1,604
| -10% | -$53.6K | 0.02% | 309 |
|
|
2016
Q2 | $525K | Sell |
15,714
-1,743
| -10% | -$55.6K | 0.03% | 294 |
|
|
2016
Q1 | $491K | Buy |
17,457
+1,346
| +8% | +$38.4K | 0.03% | 271 |
|
|
2015
Q4 | $494K | Buy |
16,111
+884
| +6% | +$27.8K | 0.02% | 300 |
|
|
2015
Q3 | $454K | Buy |
15,227
+521
| +4% | +$16.7K | 0.03% | 327 |
|
|
2015
Q2 | $468K | Buy |
14,706
+1,466
| +11% | +$47.8K | 0.03% | 303 |
|
|
2015
Q1 | $437K | Buy |
13,240
+425
| +3% | +$13.5K | 0.03% | 349 |
|
|
2014
Q4 | $378K | Sell |
12,815
-1,800
| -12% | -$51.6K | 0.02% | 365 |
|
|
2014
Q3 | $410K | Sell |
14,615
-215
| -1% | -$6.03K | 0.03% | 357 |
|
|
2014
Q2 | $418K | Sell |
14,830
-1,080
| -7% | -$30.8K | 0.03% | 339 |
|
|
2014
Q1 | $485K | Buy |
15,910
+1,216
| +8% | +$36.3K | 0.03% | 274 |
|
|
2013
Q4 | $427K | Buy |
14,694
+3,094
| +27% | +$90K | 0.03% | 259 |
|
|
2013
Q3 | $317K | Buy |
11,600
+883
| +8% | +$24K | 0.02% | 289 |
|
|
2013
Q2 | $284K | Buy |
+10,717
| New | +$296K | 0.02% | 294 |
|
Other funds holding PFE
Curi RMB Capital's PFE Position: Q2 2026 in Review
Curi RMB Capital reduced its Pfizer (PFE) stake by 5.1% in Q2 2026, selling an estimated $94.9K and leaving 67,680 shares worth $1.63M. The position accounts for 0.03% of the portfolio, ranked #377.
Curi RMB Capital first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.43M in Q4 2017. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Curi RMB Capital held 67,680 shares of Pfizer worth $1.63M as of Q2 2026.
- Curi RMB Capital sold 3,628 Pfizer shares in Q2 2026, an estimated $94.9K.
- Pfizer made up 0.03% of Curi RMB Capital's portfolio in Q2 2026, its #377 holding.
- Curi RMB Capital first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Curi RMB Capital's Pfizer position peaked at $7.43M in Q4 2017.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.